Clinical trial
The Efficacy and Safety of Ilaprazole/Doxycycline-based Bismuth-containing Quadruple Therapy on Hp Infected Duodenal Ulcers: A Randomized, Parallel-controlled Multi-center Study
NCT03342456 is registered in ClinicalTrials.gov with The Third Xiangya Hospital of Central South University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy and Safety of Ilaprazole/Doxycycline-based Bismuth-containing Quadruple Therapy on Hp Infected Duodenal Ulcers: A Randomized, Parallel-controlled Multi-center Study
- Lead sponsor
- The Third Xiangya Hospital of Central South University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 13, 2017
- Completion date
- September 20, 2019
- Enrollment
- 184 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
duodenal ulcer due to helicobacter pylori